P

Peptomyc

19 employees

Peptomyc focuses on the development of a new generation of cell-penetrating peptides targeting the Myconcoprotein for cancer treatment.

Basic info

Industry

research services

Sectors

VHIO
Biotechnology
Health Care
NSCLC
Myc
Glioblastoma
Wellness
Oncology
Breast cancer

Date founded

2014

Funding rounds raised

Total raised

$14M

from 12 investors over 12 rounds

P

Peptomyc raised $3.3M on January 18, 2022

Investors: Alta Life Sciences and Healthequity, SCR

P

Peptomyc raised $14M on December 15, 2020

Investors: AurorA Science, Alta Life Sciences, Healthequity, SCR and CDTI, Centre for the Development of Industrial Technology

P

Peptomyc raised $5M on September 11, 2017

Investors: Alta Life Sciences

P

Peptomyc raised $231K on May 3, 2017

Investors: Ministerio de Asuntos Económicos y Transformación Digital

P

Peptomyc raised $904K on November 30, 2016

Investors: European Commission and Ministerio de Asuntos Económicos y Transformación Digital

P

Peptomyc raised $1.1M on April 27, 2016

Investors: Healthequity, SCR

P

Peptomyc raised $54K on January 3, 2016

Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)

FAQ